Representing Companies In FDA & State Action Enforcement Matters

Eric F. Greenberg, P.C., located in Chicago, Illinois, represents companies throughout the United States before the Food and Drug Administration (FDA) and relevant state department in disputes regarding inspections and violations of food processing, production, growing, and packaging plants, and transportation violations.

When a company has been accused of violating a food and drug law or public health statute, there are potential federal and state enforcement actions, and consumer personal injuries. We represent these companies and help them try to minimize damages and strengthen their company despite injury or violation.

Food & Drug Law, Packaging Law, & Food Contamination

For 30 years we have been helping companies resolved federal, state, and consumer issues regarding food and drug law, and packaging law. We have successfully assisted clients regain market strength and presence. When food poisoning outbreak is alleged to be caused or is caused by your product, i.e., the spinach outbreak, turn to us. We can help you get back into production with FDA approval. We can help you prepare new food, product, and packaging guidelines for prevention of future FDA or state agency violations. And, we will assist in litigation arising from personal injury liability claims.

State Public Health Actions & Federal FDA Actions

It is important to remember that both state and federal laws must be complied with when considering food, drug or packaging standards. Contact Eric F. Greenberg to speak with a food and drug lawyer with 30 years of experience around the country.

Nationwide Representation. Call 312-977-4647

The law firm of Eric F. Greenberg, P.C., located in Chicago, Illinois, represents clients in food and drug law, packaging law, and food chain national security. The attorneys serve clients throughout the United States, from New York to California, Minnesota to Texas.

GRAS Goes to Congress

GRAS Goes to Congress

By Eric F. Greenberg, Attorney-at-law

Remember that whole business involving NGOs and other folks objecting to the legal system that allows companies to self-determine that their uses of substances are Generally Recognized As Safe (“GRAS”)? And remember how some groups had gone to court to get the system declared unlawful, but late last year the court ruled against them? Well, there’s a new chapter to this story. Now, some members of Congress have proposed a bill that would make changes to the law to address those very same objections.

The GRAS pathway to clearance of the use of substances in packaging and in food is crucially important, and this proposed law has the potential to make enormous changes in various legal obligations. For that reason, packagers should keep a close eye on this latest chapter in the ongoing debate over the policy issues surrounding the GRAS system.

In my view, addressing the complaints we’ve heard for years about the GRAS program required changes in the law, so at least the objectors are in the correct forum. There’s been so much criticism of the Food and Drug Administration lately, what with its slow reaction to the infant formula contamination problem, on top of its handling of issues relating to heavy metals in baby food and various complaints about its handling of COVID and other drug approvals, for some examples. But when it comes to the GRAS program, it’s always seemed that most of the objectors’ objections were better directed at Congress than at FDA.

You have questions, We have answers. Request a consult.

Our Office Location

303 East Wacker Drive Suite 305
Chicago, IL 60601

Phone: 312-977-4647